The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-(2,4-difluorophenylamino)pyrimidin-2-ylamino)benzenesulfonamide ID: ALA249318
PubChem CID: 25138034
Max Phase: Preclinical
Molecular Formula: C16H13F2N5O2S
Molecular Weight: 377.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: NS(=O)(=O)c1cccc(Nc2nccc(Nc3ccc(F)cc3F)n2)c1
Standard InChI: InChI=1S/C16H13F2N5O2S/c17-10-4-5-14(13(18)8-10)22-15-6-7-20-16(23-15)21-11-2-1-3-12(9-11)26(19,24)25/h1-9H,(H2,19,24,25)(H2,20,21,22,23)
Standard InChI Key: JYOWTZHCFGOHFU-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
2.9884 2.5735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9873 1.7467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7017 1.3340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4177 1.7471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4149 2.5772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6999 2.9860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1274 2.9921 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8430 2.5826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8428 1.7604 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5574 1.3509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2709 1.7659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2652 2.5947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5498 3.0004 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5601 0.5264 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2756 0.1164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2748 -0.7090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9894 -1.1188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7031 -0.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6977 0.1246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9826 0.5307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7015 0.5095 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.9770 1.3552 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.6936 -0.3123 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5260 0.5055 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8770 0.5108 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4198 -1.1135 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12 13 2 0
13 8 1 0
1 2 2 0
10 14 1 0
5 7 1 0
14 15 1 0
3 4 2 0
15 16 2 0
7 8 1 0
16 17 1 0
17 18 2 0
8 9 2 0
18 19 1 0
4 5 1 0
19 20 2 0
20 15 1 0
9 10 1 0
3 21 1 0
2 3 1 0
20 22 1 0
10 11 2 0
21 23 1 0
5 6 2 0
21 24 2 0
11 12 1 0
21 25 2 0
6 1 1 0
18 26 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 377.38Molecular Weight (Monoisotopic): 377.0758AlogP: 2.89#Rotatable Bonds: 5Polar Surface Area: 110.00Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.24CX Basic pKa: 4.22CX LogP: 3.09CX LogD: 3.09Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.63Np Likeness Score: -2.26
References 1. Bamborough P, Angell RM, Bhamra I, Brown D, Bull J, Christopher JA, Cooper AW, Fazal LH, Giordano I, Hind L, Patel VK, Ranshaw LE, Sims MJ, Skone PA, Smith KJ, Vickerstaff E, Washington M.. (2007) N-4-Pyrimidinyl-1H-indazol-4-amine inhibitors of Lck: indazoles as phenol isosteres with improved pharmacokinetics., 17 (15): [PMID:17600705 ] [10.1016/j.bmcl.2007.04.029 ]